Moscow-Sana
The First Vice President of the Russian Federal Medical and Biological Agency Tatyana Yakovleva announced that Moscow is preparing to start clinical trials of its third vaccine against the Corona virus, and that these trials will start next July.
Sputnik quoted Yakovleva as saying that "studies about the vaccine are taking place in laboratories at the center and I think that we will soon move to clinical trials, and probably next July," explaining that the vaccine developed by the agency's specialists will give in addition to mixed immunity cellular immunity.
It is noteworthy that two local vaccines were registered by the Ministry of Health in Russia and it was the first vaccine in the world to prevent Corona made by the Gamalia Electrochemistry Research Center and is known as (Sputnik V). The Victor Center of the Russian Consumer Protection Authority also developed the APIVAC vaccine and has already begun supplying the two vaccines to Areas for vaccination campaign.